Frequently Asked Questions About Integrative Cancer Care
Clear, factual answers about integrative cancer care, precision testing and supportive care at Cellaax in Petaling Jaya, Malaysia. These answers are general education and are coordinated with your oncologist — they do not replace advice from your treating doctor.
Integrative Cancer Care
What integrative cancer care is, how it works with conventional treatment, and how it differs from alternative care.
What is integrative cancer care?
Integrative cancer care combines conventional oncology treatment with evidence-informed supportive therapies, coordinated by a doctor and delivered alongside your oncologist. It addresses the whole person — nutrition, immunity, energy and emotional wellbeing — rather than the tumour alone. At Cellaax, our doctor-led integrative cancer care in Malaysia is designed to complement, not replace, your conventional treatment.
How does integrative cancer care work alongside conventional oncology treatment?
Integrative care works alongside conventional treatment by adding supportive therapies — such as nutritional support, immune support and metabolic care — at times coordinated with your oncologist. With your permission, we share your plan and results with your existing medical team so care stays aligned. This support alongside chemotherapy and radiotherapy is intended to support your quality of life, not to replace standard treatment.
What is the difference between integrative oncology and alternative cancer treatment?
Integrative oncology combines conventional cancer treatment with complementary approaches coordinated with your oncologist, while alternative treatment is used instead of conventional care. The National Cancer Institute notes that integrative approaches are meant to be used together with standard cancer treatment, whereas alternative approaches are used in place of it. Cellaax provides integrative, doctor-led cancer care that works with your oncology team, not against it. (Source: NCI)
Can supportive cancer care help during chemotherapy or radiotherapy?
Supportive cancer care can help during chemotherapy or radiotherapy by addressing nutrition, energy, immune function and side-effect support while you undergo conventional treatment. The American Cancer Society recognises that complementary approaches may help manage treatment-related effects and improve wellbeing. Our programmes are timed with your oncologist so that supportive therapies complement, rather than interfere with, your standard treatment. (Source: ACS)
Are complementary therapies and nutritional supplements safe during cancer treatment?
Complementary therapies and nutritional supplements may be safe during cancer treatment when selected and supervised by a qualified clinician and coordinated with your oncologist. The NCCIH advises telling your healthcare team about any supplements, as some can interact with treatment. At Cellaax, supplements and complementary cancer care are personalised from your test results and reviewed with your oncology team to support safe, coordinated care. (Source: NCCIH)
Cancer Types
How Cellaax's integrative approach is tailored to specific cancer types, alongside your oncologist.
How is integrative care tailored to breast cancer?
Breast cancer includes several biologically distinct subtypes — hormone receptor-positive, HER2-positive and triple-negative — each with different growth drivers and treatment sensitivities. Cellaax's breast cancer programme starts with a precision molecular approach and focuses on hormone balance, with nutrition and detoxification therapies supporting how your body processes oestrogen. Every plan is designed to complement the care you receive from your oncologist.
How is integrative care tailored to lung cancer?
Lung cancer falls into two main groups: non-small cell lung cancer and small cell lung cancer. Because the lungs supply oxygen to the whole body, lung cancer can reduce the oxygen your tissues receive. Cellaax's lung cancer programme makes oxygen therapies central, alongside bio-immunotherapy, biological IV therapies and detoxification therapies for patients with a smoking or pollutant exposure history. Every plan complements your oncologist's treatment.
How is integrative care tailored to colorectal cancer?
Colorectal cancer affects the colon or rectum, and because the gut plays a key role in digestion and nutrient absorption, nutrition and gut restoration are central to supportive care. Cellaax's colorectal cancer programme uses biological IV therapies, probiotic support and therapeutic nutrition, alongside a precision blood test that profiles your tumour's biology. All therapies are coordinated with your oncologist and gastroenterology team.
How is integrative care tailored to prostate cancer?
Many prostate cancers grow slowly and some never need active treatment, while others need prompt care. Your PSA, grade and stage tell your doctor which path fits. Cellaax's prostate cancer programme uses precision testing to profile your tumour cells and guide a personalised plan, with supportive care for hormone therapy side effects coordinated with the doctor prescribing your treatment.
How is integrative care tailored to pancreatic cancer?
Pancreatic ductal adenocarcinoma is often found late and is surrounded by dense scar-like tissue that makes it difficult for immune cells and medicines to reach the tumour. Because the pancreas makes digestive enzymes and insulin, Cellaax's pancreatic cancer programme begins with digestive enzyme replacement and metabolic therapies to stabilise blood sugar, then adds precision testing and immune support. Every therapy is coordinated with your oncologist.
How is integrative care tailored to ovarian cancer?
Ovarian cancer is often found at a later stage, and CA-125 blood levels and BRCA genetics help guide decisions. Cellaax's ovarian cancer programme uses precision blood testing to profile your tumour cells and shape a personalised plan, with biological IV therapies and therapeutic nutrition supporting your wellbeing during treatment. All therapies are planned with your gynaecological oncologist.
Cancer Testing
How precision testing builds a factual starting point for your personalised plan.
What is precision cancer testing, and how can it support personalised cancer care?
Precision cancer testing analyses your cancer's biology — such as circulating tumour cells, genes, biomarkers and drug sensitivity — to help guide a personalised cancer care plan. Rather than a one-size-fits-all approach, the results help your doctor understand how your cancer may respond to different supportive therapies. At Cellaax, these results shape your medical and testing plan alongside your full clinical picture.
How is personalised integrative cancer care assessed?
Personalised integrative cancer care is assessed through precision testing, your medical history and your current treatment, then reviewed with your oncologist. Your doctor considers tumour biology, immune function, metabolic and nutritional status, and your goals before building a plan. This whole-person approach keeps your care personalised and coordinated at every stage, from diagnosis through to ongoing support.
Liquid Biopsy
Blood-based testing that gathers biological information without an invasive tissue procedure.
What is a liquid biopsy / CTC test?
A liquid biopsy is a blood-based test that looks for circulating tumour cells (CTCs) — cancer cells that may have detached from a tumour and entered the bloodstream. It gathers biological information without an invasive tissue procedure. A simple blood sample is used to identify and analyse these living cells, which may carry information about ongoing biological activity in the body. (Source: NCI)
Why does a liquid biopsy matter for my care plan?
Even people with the same diagnosis can have cancers that behave differently at the cellular level. Analysing circulating tumour cells helps build a more personal picture of your cancer. Liquid biopsy is often one of the first steps in your plan, and its results can guide gene and biomarker analysis, drug sensitivity testing and your personalised care plan.
Genetic Testing
Molecular profiling of selected cancer-related genes and alterations.
What is gene and biomarker analysis?
Gene and biomarker analysis is laboratory analysis of selected genes, gene-expression patterns and biomarkers linked to cancer activity. Two cancers with the same name can differ significantly in their biology, and these differences may influence how the cancer behaves and how it is monitored. Results are reviewed with your clinical profile to support informed discussions and planning.
Do all gene findings have established clinical relevance?
No. Molecular and genomic profiling analyses selected cancer-related genes and alterations. Some findings have established clinical relevance; others relate to trials, emerging research or are of uncertain significance. Your doctor reviews which findings matter for your care and which remain uncertain, so your plan is based on meaningful information.
Biomarker Testing
Understanding the biological markers that shape treatment decisions.
What are cancer biomarkers and why do they matter?
Cancer biomarkers are biological molecules or characteristics associated with cancer activity. They help your doctor understand how your tumour cells behave. Two cancers with the same name can differ significantly in their biology, and these differences may influence how the cancer behaves and how it is monitored, so biomarker testing helps build a more personal picture of your cancer.
Can cancer biology change over time?
Yes. Cancer can evolve under treatment pressure, so its biology may change over time. That is why precision testing can be useful at different points in your journey, not only at diagnosis. Re-testing helps your doctor see whether your cancer's biology has shifted and adjust your supportive plan accordingly, always in coordination with your oncologist.
Drug Sensitivity Testing
Laboratory observation of how your tumour cells respond to selected substances.
What is drug sensitivity testing?
Drug sensitivity testing is a laboratory assessment that observes how circulating tumour cells from your liquid biopsy respond to selected substances under controlled conditions. CTCs isolated from your blood sample are exposed to selected agents in the laboratory, and their response is recorded in a report. One diagnosis does not mean one response, so seeing how your own cells behave adds information to your strategy.
Does laboratory drug sensitivity guarantee the same response in my body?
No. Laboratory response does not guarantee the same response in the body. Drug sensitivity testing results complement, and never replace, your imaging, pathology and oncologist's advice. Your doctor reads the laboratory report alongside your full clinical picture before any supportive therapy is considered.
Supportive Care
Whole-person therapies that support nutrition, immunity, metabolism and wellbeing.
What does supportive cancer care include at Cellaax?
Supportive cancer care at Cellaax is built on seven principles — from non-toxic therapies and immunomodulation to full-spectrum nutrition, detoxification, oxygenation, microbiome restoration and emotional support. Therapies are matched to your test results and coordinated with your oncologist, with suitability decided by your doctor. Every plan addresses all seven principles at once, tuned to your diagnosis.
How is the gut microbiome assessed and supported?
Gut and microbiome analysis assesses the diversity and balance of the microorganisms in your digestive system. The gut plays a role in digestion, nutrient absorption, immune activity and metabolism, and diet, medication, antibiotics and treatment can all change it. Findings guide personalised nutrition and support strategies within your wider plan.
Consultation Preparation
What to expect and how to prepare for your first consultation.
Where can I find integrative cancer care in Malaysia?
You can find integrative cancer care in Malaysia at Cellaax, based in Petaling Jaya, Selangor. We provide doctor-led integrative cancer care that works alongside your oncologist, with an option to review reports online first for patients outside the region. To arrange a consultation, see our contact details or message our care coordinator.
How is the first consultation arranged?
Your first consultation is complimentary. Message us, and our care coordinator will find a time that suits you and your family. During the consultation, our doctor reviews your history and decides which tests answer your questions, before building a personalised plan shared with your oncologist.
Do I need a referral to come to Cellaax?
No. You can contact our care coordinator directly. With your consent, we will request your records from your treating team and keep them informed. Your oncologist stays in charge of your cancer treatment; we share our findings with them and add nothing without their agreement.
What should I bring to a case review?
Bring your pathology and imaging reports, a list of current medicines, and your treatment history so far. These help our doctor review your case and decide which precision tests answer your questions. With your permission, we then write to your oncologist before anything is added to your plan.
Medical review status: These answers are general education grounded in existing site content and are pending medical review by the named medical practitioner. They do not constitute medical advice and do not replace advice, diagnosis or treatment from a qualified healthcare professional. Do not delay, stop or change prescribed treatment based on this page.

Still have questions?
Speak with our team about integrative cancer care in Malaysia, alongside your oncologist. Your first consultation is complimentary.
